Product image of Metfogamma (Metformin Hydrochloride) supplied by GNH India

Metfogamma

Active Ingredient:
Metformin Hydrochloride
Origin:
EU

Metfogamma (Metformin Hydrochloride)

Metformin Hydrochloride, the active ingredient in Metfogamma, is a biguanide presented as an oral dosage form for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, thereby helping lower blood‑sugar levels.

GNH India supplies Metfogamma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies, clinics and procurement teams worldwide.

Manufacturer / TM Owner

Wörwag Pharma Gmbh & Co. Kg

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Metfogamma (metformin hydrochloride) is indicated for conditions related to impaired glucose metabolism, primarily type 2 diabetes mellitus.

  • Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels.
  • Prediabetes: lowers fasting glucose and helps prevent progression to diabetes.
  • Polycystic ovary syndrome (PCOS): assists in restoring ovulatory cycles and reducing insulin resistance.

How It Works

  • Metformin hydrochloride acts primarily by inhibiting mitochondrial respiratory‑chain complex I, which reduces hepatic gluconeogenesis. It also increases peripheral glucose uptake by activating AMP‑activated protein kinase (AMPK), enhancing insulin sensitivity in muscle and adipose tissue, and modestly decreasing intestinal glucose absorption.

Side Effects

Metfogamma may cause a range of adverse reactions, from mild to serious.

Common Side Effects

  • Nausea: transient gastrointestinal discomfort.
  • Diarrhea: loose stools, often early in therapy.
  • Abdominal discomfort: cramping or bloating.
  • Metallic taste: transient alteration of taste perception.
  • Weight loss: modest reduction in body weight.
  • Vitamin B12 deficiency: decreased absorption over long‑term use.

Serious or Rare Side Effects

  • Lactic acidosis: rare but potentially fatal metabolic acidosis.
  • Severe hypoglycemia: usually when combined with insulin or sulfonylureas.
  • Hepatic dysfunction: elevated liver enzymes.
  • Pancreatitis: inflammation of the pancreas.
  • Skin reactions: rash or Stevens‑Johnson syndrome.
  • Renal impairment: worsening kidney function in susceptible patients.

Precautions & Warnings

Metfogamma requires careful monitoring and patient education to minimise risks.

  • Renal function assessment: evaluate creatinine clearance before initiation and periodically.
  • Hepatic function monitoring: check liver enzymes in patients with liver disease.
  • Lactic acidosis risk: avoid in patients with conditions predisposing to hypoxia or severe infection.
  • Concomitant medication review: assess for drugs that may increase metformin levels.
  • Dose adjustment in elderly: consider lower starting dose and slower titration.
  • Store at ambient temperature: keep in the original container, protect from moisture and heat.

Avoid Interactions

Metfogamma can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid)

  • Iodinated contrast agents: may precipitate acute renal failure and increase lactic acidosis risk.
  • Alcohol: potentiates risk of lactic acidosis.
  • Coadministration with insulin or sulfonylureas: can cause severe hypoglycemia.

Moderate Interactions (Monitor Closely)

  • Cimetidine: may increase metformin plasma concentrations.
  • Loop diuretics (e.g., furosemide): can affect renal clearance.
  • Beta‑blockers: may mask hypoglycemia symptoms.
  • ACE inhibitors or ARBs: monitor renal function and potassium levels.
  • Oral contraceptives: may slightly increase metformin levels.

Frequently Asked Questions

Metfogamma contains metformin hydrochloride and is used to improve blood‑sugar control in adults with type 2 diabetes mellitus. It may also be prescribed for prediabetes and, in some regions, for polycystic ovary syndrome to address insulin resistance.

Metformin hydrochloride reduces hepatic glucose production by inhibiting mitochondrial complex I and activates AMP‑activated protein kinase, which increases peripheral insulin sensitivity and glucose uptake in muscle and fat tissue, thereby lowering circulating glucose levels.

The dosage of Metfogamma is individualized by the prescribing clinician based on the patient’s glycemic targets, renal function, and tolerability. The prescriber determines the appropriate strength, frequency, and titration schedule.

Safety of metformin during pregnancy or lactation depends on clinical judgment. While some guidelines allow its use for gestational diabetes, the decision should be made by a qualified healthcare professional after weighing potential benefits and risks.

To order Metfogamma, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any necessary import documentation.

Metfogamma (metformin) belongs to the biguanide class and is often first‑line therapy because it does not cause weight gain and has a low risk of hypoglycemia compared with sulfonylureas or insulin. It is generally less expensive than newer agents such as SGLT2 inhibitors or GLP‑1 receptor agonists.

Metfogamma should be stored at ambient temperature, below 25 °C, in its original packaging to protect it from moisture and light. Keep the product out of reach of children and do not use it after the expiry date.

Metfogamma is taken orally, usually with meals to reduce gastrointestinal discomfort. Tablets should be swallowed whole with a full glass of water and not crushed or chewed unless specifically instructed by a healthcare professional.

The most serious adverse reaction is lactic acidosis, a rare but potentially fatal condition that can occur in patients with severe renal impairment, hepatic disease, or conditions causing hypoxia. Prompt medical attention is required if symptoms such as rapid breathing, muscle pain, or abdominal discomfort develop.

Metfogamma is contraindicated in patients with known hypersensitivity to metformin, severe renal impairment (eGFR < 30 mL/min/1.73 m²), acute or chronic metabolic acidosis, including diabetic ketoacidosis, and in those receiving iodinated contrast media without adequate renal monitoring.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Metformin Hydrochloride

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT